Perno CF - Search Results

1

Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro.

Salpini R, Surdo M, Warner N, Cortese MF, Colledge D, Soppe S, Bellocchi MC, Armenia D, Carioti L, Continenza F, Di Carlo D, Saccomandi P, Mirabelli C, Pollicita M, Longo R, Romano S, Cappiello G, Spanò A, Trimoulet P, Fleury H, Vecchiet J, Iapadre N, Barlattani A, Bertoli A, Mari T, Pasquazzi C, Missale G, Sarrecchia C, Orecchini E, Michienzi A, Andreoni M, Francioso S, Angelico M, Verheyen J, Ceccherini-Silberstein F, Locarnini S, Perno CF, Svicher V. Salpini R, et al. Among authors: perno cf. Oncotarget. 2017 Feb 28;8(9):15704-15715. doi: 10.18632/oncotarget.14944. Oncotarget. 2017. PMID: 28152517 Free PMC article.

2

Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir.

Aquaro S, Caliò R, Balzarini J, Bellocchi MC, Garaci E, Perno CF. Aquaro S, et al. Among authors: perno cf. Antiviral Res. 2002 Aug;55(2):209-25. doi: 10.1016/s0166-3542(02)00052-9. Antiviral Res. 2002. PMID: 12103427 Review.

3

Virologic correlates of adherence to antiretroviral medications and therapeutic failure.

Perno CF, Ceccherini-Silberstein F, De Luca A, Cozzi-Lepri A, Gori C, Cingolani A, Bellocchi MC, Trotta MP, Piano P, Forbici F, Scasso A, Vullo V, d'Arminio Monforte A, Antinori A; AdICoNA Study Group. Perno CF, et al. J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S118-22. doi: 10.1097/00126334-200212153-00006. J Acquir Immune Defic Syndr. 2002. PMID: 12562033 Review.

4

Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation.

Zaccarelli M, Perno CF, Forbici F, Cingolani A, Liuzzi G, Bertoli A, Trotta MP, Bellocchi MC, Di Giambenedetto S, Tozzi V, Gori C, D'Arrigo R, De Longis P, Noto P, Girardi E, De Luca A, Antinori A. Zaccarelli M, et al. Among authors: perno cf. Antivir Ther. 2003 Feb;8(1):51-6. Antivir Ther. 2003. PMID: 12713064

5

Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy.

Zaccarelli M, Perno CF, Forbici F, Soldani F, Bonfigli S, Gori C, Trotta MP, Bellocchi MC, Liuzzi G, D'Arrigo R, De Longis P, Boumis E, Bellagamba R, Tozzi V, Narciso P, Antinori A. Zaccarelli M, et al. Among authors: perno cf. Clin Infect Dis. 2004 Feb 1;38(3):433-7. doi: 10.1086/381097. Epub 2004 Jan 6. Clin Infect Dis. 2004. PMID: 14727218

6

The effect of number of mutations and of drug-class sparing on virological response to salvage genotype-guided antiretroviral therapy.

Ciancio BC, Trotta MP, Lorenzini P, Forbici F, Visco-Comandini U, Gori C, Bonfigli S, Bellocchi MC, Sette P, D'Arrigo R, Tozzi V, Zaccarelli M, Boumis E, Narciso P, Perno CF, Antinori A. Ciancio BC, et al. Among authors: perno cf. Antivir Ther. 2003 Dec;8(6):611-6. Antivir Ther. 2003. PMID: 14760895

7

HIV fitness and resistance as covariates associated with the appearance of mutations under antiretroviral treatment.

Perno CF, Cenci A, Piro C, D'Arrigo R, Marcon L, Ceccherini-Silberstein F, Ascoli Marchetti F, Caliò R, Antinori A. Perno CF, et al. Scand J Infect Dis Suppl. 2003;106:37-40. doi: 10.1080/03008870310009641. Scand J Infect Dis Suppl. 2003. PMID: 15000581

8

Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy.

Violin M, Cozzi-Lepri A, Velleca R, Vincenti A, D'Elia S, Chiodo F, Ghinelli F, Bertoli A, d'Arminio Monforte A, Perno CF, Moroni M, Balotta C. Violin M, et al. Among authors: perno cf. AIDS. 2004 Jan 23;18(2):227-35. doi: 10.1097/00002030-200401230-00012. AIDS. 2004. PMID: 15075540

9

Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure.

Ceccherini-Silberstein F, Erba F, Gago F, Bertoli A, Forbici F, Bellocchi MC, Gori C, D'Arrigo R, Marcon L, Balotta C, Antinori A, Monforte AD, Perno CF. Ceccherini-Silberstein F, et al. Among authors: perno cf. AIDS. 2004 Aug 20;18(12):F11-9. doi: 10.1097/01.aids.0000131394.76221.02. AIDS. 2004. PMID: 15280771

10

Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages.

Aquaro S, Svicher V, Ceccherini-Silberstein F, Cenci A, Marcuccilli F, Giannella S, Marcon L, Caliò R, Balzarini J, Perno CF. Aquaro S, et al. Among authors: perno cf. J Antimicrob Chemother. 2005 Jun;55(6):872-8. doi: 10.1093/jac/dki104. Epub 2005 Apr 21. J Antimicrob Chemother. 2005. PMID: 15845785

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

708 results

Search Page